Macular oedema treatment to be available on PBS


macular degeneration - closeup on eye with lots of high tech crosshairs

A government subsidy for a biologic to treat vision impairment caused by macular oedema in patients with diabetes or retinal vein occlusion (branch or central) will be available from 1 July.



This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Register here

Forgot Password?

Previous CMA calls for less health red tape, more innovation support
Next Don't mandate country of origin labelling: ASMI

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.